BioSpace News Archive

Drug Development

Spirit of ALS Patient Drives NeuroSense Mission to Bring PrimeC to Market

A meeting with an amyotrophic lateral sclerosis (ALS) patient in Israel who could only speak with the assistance of a computer changed the life and direction of NeuroSense CEO Alon Ben-Noon.

March 30, 2022
·
4 min read
·
Alex Keown
Biotech Bay

$100M Richer, Neuron23 Introduces LRRK2 inhibitor for Parkinson’s

Neuron23 announced today that it closed a $100 million Series C financing round led by SoftBank Vision Fund 2.

March 30, 2022
·
3 min read
·
Hayley Shasteen
Business

BioNTech Set to Join Ranks of Largest Drugmakers in the World

After manufacturing more than 2.6 billion doses of the Comirnaty COVID-19 vaccine together, Pfizer’s partner BioNTech is reporting skyrocketing profits.

March 30, 2022
·
3 min read
·
Hannah Chudleigh
Business

Pursuit of Scientific Challenges Drives New CODA CSO Susan Catalano

Susan Catalano, Ph.D., joined CODA Biotherapeutics as chief scientific officer after 14 years as CEO of Cognition Therapeutics, the company she founded in 2007 and took public in 2021.

March 30, 2022
·
5 min read
·
Gail Dutton
Drug Development

Study Suggests Far-UV Light Could Save Us from the Next Pandemic

Researchers have developed a new form of UV light that is safe for people but decreased the level of indoor airborne microbes by more than 98% in less than five minutes.

March 30, 2022
·
3 min read
·
Mark Terry
Drug Development

Identifying Missing Links - and Why Certain Drugs Don’t Work - in Alzhiemer’s

A team at the University of California, San Diego developed a drug screening method to help determine why Alzheimer’s drugs fail. The system analyzes disease mechanisms in human neurons.

March 30, 2022
·
5 min read
·
Mark Terry
Money on the Move: March 23-29

This week, money moved in the form of equity financing, upfront partnership payments, nonprofit donations and federal funding.

March 30, 2022
·
4 min read
·
Hannah Chudleigh
Drug Development

Amylyx ALS Candidate Denied in Painfully Close AdCom Vote (Updated)

In a meeting of the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee, six members voted not to approve the NDA for Amylyx’s ALS candidate, AMX0035, while four voted in favor.

March 30, 2022
·
4 min read
·
Heather McKenzie
Electrophoresis Market: Surge in awareness about personalized therapeutics to drive the market

Albany NY, United States: Electrophoresis technique is used to physically separate macromolecules such as RNA, nucleic acid fragments, and proteins according to their molecular size and electric charge.

March 30, 2022
·
5 min read
Blood Warmer Devices/Sample Warmer Market Development and Emerging Trends Analysis - Technological Advancement in the Healthcare Industry

The global market for blood warmer devices/sample warmers has witness steady expansion in the recent years and continues to expand at a promising pace.

March 30, 2022
·
6 min read